|
1
|
Fan F, Schimming A, Jaeger D and Podar K:
Targeting the tumor microenvironment: Focus on angiogenesis. J
Oncol. 2012:2812612012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hida K, Kawamoto T, Ohga N, Akiyama K,
Hida Y and Shindoh M: Altered angiogenesis in the tumor
microenvironment. Pathol Int. 61:630–637. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao H, Xu R, Ouyang Q, Chen L, Dong B and
Huihua Y: Contrast-enhanced ultrasound is helpful in the
differentiation of malignant and benign breast lesions. Eur J
Radiol. 73:288–293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vallone P, D'Angelo R, Filice S, Petrosino
T, Rinaldo M, De Chiara A and Gallipoli A: Color-doppler using
contrast medium in evaluating the response to neoadjuvant treatment
in patients with locally advanced breast carcinoma. Anticancer Res.
25:595–599. 2005.PubMed/NCBI
|
|
5
|
Du J, Li FH, Fang H, Xia JG and Zhu CX:
Correlation of real-time gray scale contrast-enhanced
ultrasonography with microvessel density and vascular endothelial
growth factor expression for assessment of angiogenesis in breast
lesions. J Ultrasound Med. 27:821–831. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wan CF, Du J, Fang H, Li FH, Zhu JS and
Liu Q: Enhancement patterns and parameters of breast cancers at
contrast-enhanced US: Correlation with prognostic factors.
Radiology. 262:450–459. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
American College of Radiology (ACR), .
Breast Imaging Reporting and Data System Atlas (BI-RADS Athas).
4th. ACR; Reston, VA: 2013
|
|
8
|
Lakhani SR, Ellis IO, Schnitt SJ, Tan PH
and van de Vijver MJ: WHO Classification of Tumours of the Breast.
4. 4th. IARC Press; 2012
|
|
9
|
Elston CW and Ellis IO: Pathological
prognostic factors in breast cancer. I. The value of histological
grade in breast cancer: Experience from a large study with
long-term follow-up. Histopathology. 41:154–151. 2002.PubMed/NCBI
|
|
10
|
AJCC Cancer Staging Handbook: From the
AJCC Cancer Staging Manual. Edge S, Byrd DR, Compton CC, Fritz AG,
Greene F and Trotti A: 7th. Springer-Verlag; NY: 2010
|
|
11
|
Liu F, Lang R, Zhao J, Zhang X, Pringle
GA, Fan Y, Yin D, Gu F, Yao Z and Fu L: CD8+ cytotoxic T
cell and FOXP3+ regulatory T cell infiltration in relation to
breast cancer survival and molecular subtypes. Breast Cancer Res
Treat. 130:645–655. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hammond ME, Hayes DF, Dowsett M, Allred
DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS,
Hayes M, et al: American Society of Clinical Oncology/College of
American Pathologists guideline recommendations for
immunohistochemical testing of estrogen and progesterone receptors
in breast cancer (unabridged version). Arch Pathol Lab Med.
134:e48–e72. 2010.PubMed/NCBI
|
|
13
|
Cheang MC, Chia SK, Voduc D, Gao D, Leung
S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, et al: Ki67
index, HER2 status, and prognosis of patients with luminal B breast
cancer. J Natl Cancer Inst. 101:736–750. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Buadu LD, Murakami J, Murayama S,
Hashiguchi N, Sakai S, Masuda K, Toyoshima S, Kuroki S and Ohno S:
Breast lesions: Correlation of contrast medium enhancement patterns
on MR images with histopathologic findings and tumor angiogenesis.
Radiology. 200:639–649. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu H, Jiang YX, Liu JB, Zhu QL and Sun Q:
Evaluation of breast lesions with contrast-enhanced ultrasound
using the microvascular imaging technique: Initial observations.
Breast. 17:532–539. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nagy JA, Chang SH, Shih SC, Dvorak AM and
Dvorak HF: Heterogeneity of the tumor vasculature. Semin Thromb
Hemost. 36:321–331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jackson A, O'Connor JP, Parker GJ and
Jayson GC: Imaging tumor vascular heterogeneity and angiogenesis
using dynamic contrast-enhanced magnetic resonance imaging. Clin
Cancer Res. 13:3449–3459. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Teifke A, Behr O, Schmidt M, Victor A,
Vomweg TW, Thelen M and Lehr HA: Dynamic MR imaging of breast
lesions: Correlation with microvessel distribution pattern and
histologic characteristics of prognosis. Radiology. 239:351–360.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kushlinskii NE, Orinovskii MB, Gurevich
LE, Kazantseva IA, Talaeva ShZh, Shirokii VP, Ermilova VD, Dvorova
EK and Ozherelev AS: Expression of biomolecular markers (Ki-67,
PCNA, Bcl-2, BAX, BclX, VEGF) in breast tumors. Bull Exp Biol Med.
137:182–185. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Weidner N, Folkman J, Pozza F, Bevilacqua
P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis:
A new significant and independent prognostic indicator in
early-stage breast carcinoma. J Natl Cancer Inst. 84:1875–1887.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fridman V, Humblet C, Bonjean K and
Boniver J: Assessment of tumor angiogenesis in invasive breast
carcinomas: Absence of correlation with prognosis and pathological
factors. Virchows Arch. 437:611–617. 2000. View Article : Google Scholar : PubMed/NCBI
|
